Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ED-71 on Incident Fractures in Osteoporotic Patients
jRCT2080220020Phase 3
- Sponsor
- Chugai Pharmaceutical Co., Ltd.
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of eldecalcitol in osteoporosis, sponsored by Chugai Pharmaceutical Co., Ltd. Primary endpoint: incident fractures.
02
Drugs
eldecalcitol
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT2080220020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220020.